We are live on
!
Find out more
BTTX
Better Therapeutics, Inc. Common Stock
BTTX
BTTX
Delisted
BTTX was delisted on the 15th of March, 2024.
17 hedge funds and large institutions have $1.75M invested in Better Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
88% more call options, than puts
Call options by funds: $360K | Put options by funds: $191K
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 16 → 17 (+1)
44% less capital invested
Capital invested by funds: $3.11M → $1.75M (-$1.37M)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
17
Holders Change
+1
Holders Change %
+6.25%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
6
Closed
2
Calls
$360K
Puts
$191K
Net Calls
+$169K
Net Calls Change
-$106K
Top Buyers
| 1 |
Group One Trading
Chicago,
Illinois
|
+$29.9K |
| 2 |
BlackRock
New York
|
+$2.43K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$302 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$199 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$27 |
